PFE logo Pfizer +
Pfizer
+

Pfizer (PFE) Business News

Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
6:52 AM | Thursday | Jun 18, 2026 Reuters

Pfizer CFO Dave Denton to step down, leave company in August

NEW News Thumbnail
6:45 AM | Thursday | Jun 18, 2026 Business Wire

Pfizer Announces Chief Financial Officer Transition

NEW News Thumbnail
3:14 PM | Wednesday | Jun 17, 2026 Seeking Alpha

Pfizer: Why I'm Still Expecting A Massive Rebound

News Thumbnail
3:21 PM | Tuesday | Jun 16, 2026 24/7 Wall Street

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

News Thumbnail
3:21 PM | Tuesday | Jun 16, 2026 24/7 Wall Street

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

News Thumbnail
11:06 AM | Monday | Jun 15, 2026 Zacks Investment Research

Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?

News Thumbnail
10:00 AM | Monday | Jun 15, 2026 Zacks Investment Research

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

News Thumbnail
11:26 AM | Saturday | Jun 13, 2026 247 Wallst

3 Stocks With a Yield Over 6% For Passive Income Investors

News Thumbnail
12:32 PM | Friday | Jun 12, 2026 Fool - Investing News

Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

News Thumbnail
10:47 AM | Friday | Jun 12, 2026 24/7 Wall Street

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

News Thumbnail
11:36 AM | Thursday | Jun 11, 2026 Fool - Investing News

Why Pfizer Stock Popped Today

News Thumbnail
9:45 AM | Thursday | Jun 11, 2026 Fool - Investing News

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?

News Thumbnail
7:59 AM | Wednesday | Jun 10, 2026 247 Wallst

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

News Thumbnail
7:56 AM | Wednesday | Jun 10, 2026 Reuters

Pfizer CEO warns German investment at risk over drug pricing policies

News Thumbnail

Pfizer CFO Dave Denton to step down, leave company in August

Reuters

6:52 AM | Thursday | Jun 18, 2026

news photo
Loading...

Pfizer said on ​Thursday that finance ‌chief Dave Denton will step down and ​leave the company ​on August 15 to ⁠take a role ​in the consumer goods ​industry.

Read full article redirect
6:52 AM | Thursday | Jun 18, 2026

Pfizer CFO Dave Denton to step down, leave company in August

Reuters

Pfizer said on ​Thursday that finance ‌chief Dave Denton will step down and ​leave the company ​on August 15 to ⁠take a role ​in the consumer goods ​industry.

Read full article arrow
NEW News Thumbnail
6:45 AM | Thursday | Jun 18, 2026

Pfizer Announces Chief Financial Officer Transition

Business Wire

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that Dave Denton, Chief Financial Officer, will step down from his current role and leave the company on August 15 for a professional opportunity outside of the pharmaceutical industry in consumer goods, which he has accepted. The company has named Cecile Guegan, currently Senior Vice President, Finance, Global Biopharmaceutical Business, as Interim Chief Financial Officer, effective August 16, while Pfizer conducts a comprehens.

Read full article arrow
NEW News Thumbnail
3:14 PM | Wednesday | Jun 17, 2026

Pfizer: Why I'm Still Expecting A Massive Rebound

Seeking Alpha

Pfizer Inc. remains a Buy with 55%+ upside potential over two years, driven by a robust pipeline and undervalued forward earnings. PFE's Q1 2026 results beat estimates, with non-COVID sales up 7% YoY and strong contributions from Seagen and new product launches. Key catalysts include the potential blockbuster GLP-1 candidate berobenatide, aggressive oncology growth, and patent settlements extending revenue streams.

Read full article arrow
News Thumbnail
3:21 PM | Tuesday | Jun 16, 2026

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

24/7 Wall Street

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.

Read full article arrow
News Thumbnail
3:21 PM | Tuesday | Jun 16, 2026

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

24/7 Wall Street

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.

Read full article arrow
News Thumbnail
11:06 AM | Monday | Jun 15, 2026

Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?

Zacks Investment Research

PFE trades at a steep discount as COVID sales fade and patent cliffs loom, but new products, oncology strength and pipeline plans could shape its future.

Read full article arrow
News Thumbnail
10:00 AM | Monday | Jun 15, 2026

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

Zacks Investment Research

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
11:26 AM | Saturday | Jun 13, 2026

3 Stocks With a Yield Over 6% For Passive Income Investors

247 Wallst

Passive income arrives while you sleep, commute, or vacation. That appeal drives dividend investing: a paycheck every quarter regardless of market conditions or work hours. Layoff announcements have rattled white-collar industries through the first half of 2026, and essentials costs climb faster than most household raises. Building a cash-flowing portfolio is one of the few..
. 3 Stocks With a Yield Over 6% For Passive Income Investors

Read full article arrow
News Thumbnail
12:32 PM | Friday | Jun 12, 2026

Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

Fool - Investing News

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Read full article arrow
News Thumbnail
10:47 AM | Friday | Jun 12, 2026

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

24/7 Wall Street

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to own right now, a $1.02 trillion obesity juggernaut that has ripped 20.9% higher in a single month on the back of the

Read full article arrow
News Thumbnail
11:36 AM | Thursday | Jun 11, 2026

Why Pfizer Stock Popped Today

Fool - Investing News

Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell.

Read full article arrow
News Thumbnail
9:45 AM | Thursday | Jun 11, 2026

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?

Fool - Investing News

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow. See how their fundamentals stack up.

Read full article arrow
News Thumbnail
7:59 AM | Wednesday | Jun 10, 2026

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

247 Wallst

Pre-Market Stock Futures: Futures are trading lower after the stock market tried to take a cue from Monday's action, and things didn't work out quite as well on Tuesday. Once again, the market gapped open higher as the "Buy the dip" legions came in to ride what they thought would be another wave higher, only... Here Are Wednesday's Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Read full article arrow
News Thumbnail
7:56 AM | Wednesday | Jun 10, 2026

Pfizer CEO warns German investment at risk over drug pricing policies

Reuters

Pfizer is ‌reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said ​in a letter to Chancellor Friedrich ​Merz, citing the government's policy proposals ⁠that would lower drug prices.

Read full article arrow
News Thumbnail